MRD Minimal Residual Disease Testing Market
MRD Minimal Residual Disease Testing Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
MRD Minimal Residual Disease Testing Market Size and Growth
The MRD Minimal Residual Disease Testing market research reports provide insights into market conditions, trends, and growth drivers for this rapidly growing sector. The global MRD Minimal Residual Disease Testing market is estimated to be worth $xxx million by 2023, driven by increasing awareness and adoption of precision medicine. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ ICON plc
◍ ArcherDX(Invitae)
◍ ARUP Laboratories
◍ Asuragen
◍ Cergentis B.V.
◍ Bio-Rad Laboratories
◍ Mission Bio
◍ Guardant Health
◍ Invivoscribe
◍ LabCorp
◍ Inivata
◍ Natera
◍ NeoGenomics Laboratories
◍ Opko Health
◍ Quest Diagnostics
◍ Sysmex Corporation
◍ Adaptive Biotechnologies
The MRD Minimal Residual Disease Testing Market is highly competitive with key players such as ICON plc, ArcherDX(Invitae), ARUP Laboratories, Asuragen, Cergentis B.V., Bio-Rad Laboratories, Mission Bio, Guardant Health, Invivoscribe, LabCorp, Inivata, Natera, NeoGenomics Laboratories, Opko Health, Quest Diagnostics, Sysmex Corporation, and Adaptive Biotechnologies. These companies offer advanced technologies and solutions for MRD testing, contributing to market growth.
- Sales revenue:
- Invitae: $218 million
- NeoGenomics Laboratories: $403.6 million
- Quest Diagnostics: $9.44 billion
Request Sample Report
Market Segmentation
By Application
◍ Specialty Clinics and Hospitals
◍ Diagnostic Laboratories
◍ Research Institutions
By Product
◍ Flow Cytometry
◍ Polymerase Chain Reaction (PCR)
◍ Next-Generation Sequencing (NGS)
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients